← All indications
Typhoid Fever
An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
Drugs by status
Approved for this indication (10)
Phase 4 trials (9)
Phase 3 trials (4)
Phase 2 trials (18)
- levofloxacin
- albendazole
- arsenic
- m01zh09
- pneumococcal 13-valent conjugate vaccine
- m10zh09 vaccine
- ty21a
- ty800
- vi-crm197 vaccine
- vi-repa conjugate vaccine
- vi-tcv
- zinc dichloride
- secnidazole
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- diphtheria toxoid
- polio, inactivated poliovirus vaccine
- sodium chloride
Phase 1 trials (9)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (22)
- GlaxoSmithKline
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (NIAID)
- International Vaccine Institute
- Stanford University
- University of Maryland
- Aga Khan University
- Tel Aviv University
- University of Oxford
- Government of China
- National Institute of Cholera and Enteric Diseases, Kolkata, India
- Wellcome Trust
- University of Western Ontario
- Patan Academy of Health Sciences
- Government of Vietnam
- Patan Hospital, Nepal
- Civil Hospital, Nepal
- Hue Preventive Medicine Center, Vietnam
- University of Helsinki
- Government of United Kingdom
- Centers for Disease Control and Prevention (CDC)
- Ziauddin University
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (10)
- Avant Immunotherapeutics
- Emergent BioSolutions
- National Institutes of Health (NIH)
- International Center for Diarrheal Disease Research
- Accelovance
- University of Gothenburg
- Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila, Philippines
- SK Chemicals
- University of Antwerp
- Groupe de Recherche Action en Santé (GRAS), Burkina Faso
Organization Involved with Phase 1 Indications (5)